Women with inflammatory bowel disease (IBD) have more adverse pregnancy outcomes such as premature birth and low birthweight than women without IBD, researchers report in the June issue of Gut.
Women with inflammatory bowel disease (IBD) have more adverse pregnancy outcomes such as premature birth and low birthweight than women without IBD, researchers report in the June issue of Gut.
Paris P. Tekkis, MD, from Imperial College in London, UK, and colleagues performed a meta-analysis of 12 published studies examining pregnancy outcomes in women with IBD (Crohn's disease or ulcerative colitis). The studies included 3,907 IBD patients and 320,531 controls.
The researchers found that IBD significantly increased the risk of premature birth (relative risk of birth at less than 37 weeks, 1.87), low birthweight (less than 2,500 g, RR, 2.1), cesarean section (RR,1.5) and congenital abnormalities (RR, 2.37).
"The study has shown a higher incidence of adverse pregnancy outcomes in patients with IBD," Tekkis and colleagues conclude. "This has an effect on the management of patients with IBD during pregnancy, who should be treated as a potentially high-risk group."
Cornish J, Tan E, Teare J, et al. Meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830-837.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More